A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney disease

por Blazer-Yost, Bonnie L, Bacallao, Robert L, Erickson, Bradley J, LaPradd, Michelle L, Edwards, Marie E, Sheth, Nehal, Swinney, Kim, Ponsler-Sipes, Kristen M, Moorthi, Ranjani N, Perkins, Susan M, Torres, Vicente E, Moe, Sharon M
Publicado 2021